14 April 2015

Presentation at the Asthma and COPD Conference

VERONA PHARMA PLC - Presentation at the Asthma and COPD Conference

Read more

23 March 2015

Interim results from new RPL554 trial

VERONA PHARMA PLC - Interim results from new RPL554 trial

Read more

3 March 2015

Trading and Development Programme Update

VERONA PHARMA PLC - Trading and Development Programme Update

Read more

3 March 2015

Director’s Dealing

VERONA PHARMA PLC - Director’s Dealing

Read more

16 February 2015

Director's Dealing

Verona Pharma plc

Read more

5 February 2015

Director’s Dealing

VERONA PHARMA PLC - Director’s Dealing

Read more

30 January 2015

Grant of Share Options

VERONA PHARMA PLC - Grant of Share Options

Read more

Innovative Therapies for Respiratory Care

See the 2017 Verona Pharma corporate video 2017

Runtime: 04:05

Go

The Lancet Respiratory Medicine

Peer-reviewed paper in the Lancet's highly-respected medication journal

Basic & Clinical Pharmacology & Toxicology

Peer-reviewed publication on dual PDE3/4 inhibitors as novel treatments for COPD

Close

Verona Pharma plc
3 More London Riverside, London SE1 2RE
T: +44 (0)203 283 4200

Linkedin     Email Us